Assessment of the Frequency and Level of Knowledge of Cervical Cancer Among HIV-positive Women at the University Teaching Hospital Gabriel Toure and at the Listening, Care, Animation and Advice Center in Bamako, Mali
Fané Seydou1*, Bocoum Amadou1, Sylla Checkna1, Traoré Soumana Oumar2, Kanté Ibrahima3, Tegueté Ibrahima1, Traoré Youssouf1 and Mounkoro Niani1
1Department of Gynecology Obstetrics of UTH Gabriel Touré of Bamako, Mali
2Service of Gynecology Obstetrics of the Referral Health Center of Commune V of Bamako, Mali
3Department of Gynecology Obstetrics of UTH Point G, Bamako, Mali
*Corresponding Author: Fané Seydou, Department of Gynecology Obstetrics of UTH Gabriel Touré of Bamako, Mali.
March 17, 2022; Published: March 30, 2022
The aim of our study was to contribute to the decreasing of cervical cancer incidence in women living with HIV/AIDS. We conducted an analytical cross-sectional study over a period of three months at the university teaching hospital (UTH) Gabriel TOURE and at the listening, care, animation and advice center (LCAAC) in Bamako. We have recorded 216 HIV positive women who underwent cervical cancer screening during our study period. Among these 216 cases, 16 patients (7.4%) were positive to the VIA/VILI test. The histological results available were 8 cases out of 16 biopsies performed (50%) and the histological type was: 12.5% cases of cervicitis; 12.5% CIN, 73.5% invasive cancer. Monogamous married women were significantly represented. The most dominant age group was 45-64 years (38.42%). Women out of school accounted for 66.2%. The initial viral load (chi-square = 11.149; p = 0.011), compliance with treatment (chi-square = 5.023; p = 0.025), history of sexually transmitted infection (STI) (Khi-square = 14.860, Ddl = 3, P = 0.002, type of STI treatment (Khi-square = 14.860; Ddl = 4; P = 0.005). knowledge about the existence of HPV vaccine (Chi-square = 5.260; P = 0.022) were the most found risk factors and represented respectively 67.12% of recent CD4 counts below 500 cells/mm3, 44.44%; 29.34% and 3.1%. The rate of management of precancerous and cancerous lesions of the cervix was 50%. Conclusion: The frequency of cervical cancer is high in HIV-positive women. The level of knowledge about cervical cancer is low. A decrease in its frequency in HIV-positive women requires management of risk factors.
Keywords: Frequency; Level of Knowledge; HIV-positive; Cervical Cancer; UTH Gabriel Toure; LCAAC
- Walboomers JM., et al. “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide”. Journal of Pathology 189 (1999): 12-19.
- “Center of Disease Control”. de 1993 (anonymous 1993 revised classification system for HIV infection).
- Francheschi S and Jaffe H. “Cervical cancer screening of women living with HIV: a must in the post-ART era”. Clinical Infectious Diseases 45 (2007): 510-513.
- Clifford GM., et al. “Human papilloma virus types in invasive cervical cancer worldwide: meta-analysis”. British Journal of Cancer1 (2003): 63-73.
- Massad LS., et al. “Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women’s interagency HIV study”. Journal of Acquired Immune Deficiency Syndromes 27 (2001): 432-442.
- Schuman P., et al. “Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women”. Journal of Infectious Diseases 188 (2003): 128-136.
- Stein L., et al. “The spectrum of human deficiency virus associated cancers in a South Africa black population, resultants from a case-control study 95-2004”. International Journal of Cancer 22 (2008): 2260-2265.
- Leroy V., et al. “Cervical dysplasia and HIV type infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE)”. Sexually Transmitted Infections 75 (1999): 103-106.
- Engels EA., et al. “Trends in cancer risk among people with AIDS in the United States 1980-2002”. AIDS 20 (2006): 1645-1654.
- Newnham A., et al. “The risk of cancer in HIV-infected people in southeast England: a cohort study”. British Journal of Cancer 92 (2005): 194-200.
- Mbulaiteye SM., et al. “Spectrum of cancers among HIV-infected persons in Africa: The Uganda AIDS-Cancer Registry Match Study”. International Journal of Cancer 118 (2006): 985-990.
- Abdoulaye SISSOKO, precancerous lesions of the cervix, prevalence and factors influencing their occurrence in HIV-positive women followed at LCAAC in Bamako, final dissertation in gynecology and obstetrics 2010-2011.
- Nienke J Veldhuijzen., et al. “The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda”. BMC Infectious Diseases 11 (2011): 333.
- Didelot-Rousseau MN., et al. “Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso”. British Journal of Cancer 95 (2006): 355-362.
- JACQUET A. “Cervix cancers and HIV infection in West Africa, Descriptive epidemiology, determinants and screening, thesis number 1979 for the doctorate of the University of Bordeaux 2” (2012).
- Veldhuijzen Nienke J., et al. “The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda”. BMC Infectious Diseases 11 (2011): 333.
- Vikrant V Sahasrabuddhe., et al. “Prevalence and Predictors of Colposcopic-Histopathologically Confirmed Cervical Intraepithelial, Neoplasia in HIV-Infected Women in India”. PLoS ONE 1 (2010): e8634.
- Luchters S., et al. “Impact of five years of peer-mediated interventions on sexual behavior and sexually transmitted infections among female sex workers in Mombasa, Kenya”. BMC Public Health 8 (2008): 143.
- Delmas MC., et al. “Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV infection in Women”. AIDS 14 (2000): 1775-1784.
- Strickler HD., et al. “Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women”. Journal of the National Cancer Institute 97 (2005): 577-586.
- Six C., et al. “Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women”. AIDS 12 (1998): 1047-1056.
- Harris TG., et al. “Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results”. Journal of the American Medical Association 293 (2005): 1471-1476.
- Sobesky M., et al. “Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults”. Journal of the National Cancer Institute 92 (2000): 1823-1830.
- Chin-Hong PV and Palefsky JM. “Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus”. Clinical Infectious Diseases 35 (2002): 1127-1134.
- Conley LJ., et al. “HlV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study”. Lancet 359 (2002): 108-113.
- De Sanjose´ S and Palefsky J. “Cervical and anal HPV infections in HIV positive women and men”. Virus Research 89 (2002): 201-211.
- Heard I., et al. “Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV- seropositive women”. AIDS 16 (2002): 1799-1802.
- Lillo FB., et al. “Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy”. Journal of Infectious Diseases 184 (2001): 547-551.
- Rama Djouedjon Dakenyo., et al. “Knowledge, attitudes and practices of women of childbearing age with regards to cervical cancer preventive measures in the MIFI health district, Cameroon”. Pan African Medical Journal 31 (2018): 172.
- Rousseau D- N Nagot., et al. “Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso”. British Journal of Cancer 95 (2006): 355-362.